Ascendis Pharma A (ASND) Long-Term Debt Repayments (2019 - 2026)
Ascendis Pharma A's Long-Term Debt Repayments was -$9.46 million in the quarter ended Jun 30, 2026, compared with -$6.21 million a year earlier.
Powered by 
Analysis
Ascendis Pharma A (ASND) Long-Term Debt Repayments (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's Long-Term Debt Repayments was -$35.14 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$24.81 million.
- In earlier years, Long-Term Debt Repayments was -$12.3 million in the year ended Dec 31, 2024, -$11.29 million in the year ended Dec 31, 2023 and -$6.7 million in the year ended Dec 31, 2022.
- Quarterly Long-Term Debt Repayments has moved between -$10.04 million (the quarter ended Mar 31, 2026) and -$2.74 million (the quarter ended Jun 30, 2023) over five years.
- Per Business Quant data, ASND's Long-Term Debt Repayments in the three quarters before the quarter ended Jun 30, 2026 was -$10.04 million (quarter ended Mar 31, 2026), -$7.96 million (quarter ended Dec 31, 2025) and -$7.68 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | 29.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.41 Mn |
| Mar 31, 2026 | -10.04 Mn |
| Dec 31, 2025 | 7.96 Mn |
| Sep 30, 2025 | 7.68 Mn |
| Jun 30, 2025 | 6.21 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.94 Mn |
| Sep 30, 2023 | 2.85 Mn |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Jun 30, 2020 | -1.31 Mn |
| Mar 31, 2020 | -1.23 Mn |
| Sep 30, 2019 | -810,067.46 |
| Jun 30, 2019 | -1.21 Mn |
| Mar 31, 2019 | -1.35 Mn |
API Access
Ascendis Pharma A Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();